Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant.

Keks NA, Hope J, Keogh S, Copolov DL.

Australas Psychiatry. 2018 Oct;26(5):537-540. doi: 10.1177/1039856218794874. Epub 2018 Sep 10.

PMID:
30198305
2.

Interhemispheric EEG coherence is reduced in auditory cortical regions in schizophrenia patients with auditory hallucinations.

Henshall KR, Sergejew AA, Rance G, McKay CM, Copolov DL.

Int J Psychophysiol. 2013 Jul;89(1):63-71. doi: 10.1016/j.ijpsycho.2013.05.005. Epub 2013 May 21.

PMID:
23707337
3.

A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania.

Magalhães PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M.

Aust N Z J Psychiatry. 2013 Jun;47(6):564-8. doi: 10.1177/0004867413481631. Epub 2013 Mar 14.

PMID:
23493756
4.

A new phenomenological survey of auditory hallucinations: evidence for subtypes and implications for theory and practice.

McCarthy-Jones S, Trauer T, Mackinnon A, Sims E, Thomas N, Copolov DL.

Schizophr Bull. 2014 Jan;40(1):231-5. doi: 10.1093/schbul/sbs156. Epub 2012 Dec 23.

5.

Effects of N-acetyl cysteine on cognitive function in bipolar disorder.

Dean OM, Bush AI, Copolov DL, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M.

Psychiatry Clin Neurosci. 2012 Oct;66(6):514-7. doi: 10.1111/j.1440-1819.2012.02392.x.

6.

Interhemispheric transfer time in patients with auditory hallucinations: an auditory event-related potential study.

Henshall KR, Sergejew AA, McKay CM, Rance G, Shea TL, Hayden MJ, Innes-Brown H, Copolov DL.

Int J Psychophysiol. 2012 May;84(2):130-9. doi: 10.1016/j.ijpsycho.2012.01.020. Epub 2012 Feb 15.

PMID:
22342240
7.

Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder.

Magalhães PV, Dean OM, Bush AI, Copolov DL, Weisinger D, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):132-5. doi: 10.1016/j.pnpbp.2011.11.011. Epub 2011 Dec 23.

PMID:
22212173
8.

N-acetylcysteine for major depressive episodes in bipolar disorder.

Magalhães PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M.

Braz J Psychiatry. 2011 Dec;33(4):374-8.

9.

N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder.

Dean OM, van den Buuse M, Berk M, Copolov DL, Mavros C, Bush AI.

Neurosci Lett. 2011 Jul 25;499(3):149-53. doi: 10.1016/j.neulet.2011.05.027. Epub 2011 May 20.

PMID:
21621586
10.

Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia.

Berk M, Munib A, Dean O, Malhi GS, Kohlmann K, Schapkaitz I, Jeavons S, Katz F, Anderson-Hunt M, Conus P, Hanna B, Otmar R, Ng F, Copolov DL, Bush AI.

J Clin Psychiatry. 2011 Jul;72(7):909-13. doi: 10.4088/JCP.09m05741yel. Epub 2010 Sep 21.

PMID:
20868637
11.

Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice.

Dean O, Bush AI, Berk M, Copolov DL, van den Buuse M.

Pharmacol Biochem Behav. 2010 Dec;97(2):293-300. doi: 10.1016/j.pbb.2010.08.013. Epub 2010 Sep 9.

PMID:
20816888
12.

N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.

Magalhães PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M.

J Affect Disord. 2011 Mar;129(1-3):317-20. doi: 10.1016/j.jad.2010.08.001. Epub 2010 Aug 30.

PMID:
20800897
13.

Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial.

Bernardo M, Dodd S, Gama CS, Copolov DL, Dean O, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI, Berk M.

Acta Neuropsychiatr. 2009 Dec;21(6):285-91. doi: 10.1111/j.1601-5215.2009.00397.x.

PMID:
25384734
14.

Effects of N-acetylcysteine on substance use in bipolar disorder: a randomised placebo-controlled clinical trial.

Bernardo M, Dodd S, Gama CS, Copolov DL, Dean O, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI, Berk M.

Acta Neuropsychiatr. 2009 Oct;21(5):239-45. doi: 10.1111/j.1601-5215.2009.00415.x.

PMID:
26952771
15.

A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.

Dean OM, van den Buuse M, Bush AI, Copolov DL, Ng F, Dodd S, Berk M.

Curr Med Chem. 2009;16(23):2965-76. Review.

PMID:
19689277
16.

Evaluation of treatment in 35 cases of bipolar suicide.

Keks NA, Hill C, Sundram S, Graham A, Bellingham K, Dean B, Opeskin K, Dorissa A, Copolov DL.

Aust N Z J Psychiatry. 2009 Jun;43(6):503-8. doi: 10.1080/00048670902873680.

PMID:
19440881
17.

Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice.

Dean O, Bush AI, Berk M, Copolov DL, van den Buuse M.

Behav Brain Res. 2009 Mar 2;198(1):258-62. doi: 10.1016/j.bbr.2008.11.017. Epub 2008 Nov 18.

PMID:
19061918
18.

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility.

Dodd S, Dean O, Copolov DL, Malhi GS, Berk M.

Expert Opin Biol Ther. 2008 Dec;8(12):1955-62. doi: 10.1517/14728220802517901 . Review.

PMID:
18990082
19.

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.

Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI.

Biol Psychiatry. 2008 Sep 15;64(6):468-75. doi: 10.1016/j.biopsych.2008.04.022. Epub 2008 Jun 5.

PMID:
18534556
20.

Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression?

Keks NA, Burrows GD, Copolov DL, Newton R, Paoletti N, Schweitzer I, Tiller J.

Med J Aust. 2007 Feb 5;186(3):142-4. Review.

PMID:
17309404

Supplemental Content

Loading ...
Support Center